Choong Ang Vaccine Laboratory Statistics

Total Valuation

Choong Ang Vaccine Laboratory has a market cap or net worth of KRW 102.37 billion. The enterprise value is 95.38 billion.

Market Cap	102.37B
Enterprise Value	95.38B

Important Dates

The next estimated earnings date is Tuesday, November 26, 2024.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	n/a

Share Statistics

Choong Ang Vaccine Laboratory has 9.56 million shares outstanding.

Shares Outstanding	9.56M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.73%
Owned by Insiders (%)	34.86%
Owned by Institutions (%)	0.49%
Float	6.23M

Valuation Ratios

The trailing PE ratio is 28.55.

PE Ratio	28.55
Forward PE	n/a
PS Ratio	2.66
PB Ratio	1.08
P/FCF Ratio	73.80
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.53, with an EV/FCF ratio of 68.76.

EV / Earnings	26.14
EV / Sales	2.43
EV / EBITDA	9.53
EV / EBIT	23.90
EV / FCF	68.76

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.12.

Current Ratio	3.11
Quick Ratio	1.71
Debt / Equity	0.12
Debt / EBITDA	1.11
Debt / FCF	8.04
Interest Coverage	14.69

Financial Efficiency

Return on equity (ROE) is 3.83% and return on invested capital (ROIC) is 2.34%.

Return on Equity (ROE)	3.83%
Return on Assets (ROA)	2.18%
Return on Capital (ROIC)	2.34%
Revenue Per Employee	234.67M
Profits Per Employee	21.85M
Employee Count	167
Asset Turnover	0.34
Inventory Turnover	1.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+0.58%
50-Day Moving Average	10,413.20
200-Day Moving Average	10,657.85
Relative Strength Index (RSI)	53.00
Average Volume (20 Days)	32,051

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Choong Ang Vaccine Laboratory had revenue of KRW 39.19 billion and earned 3.65 billion in profits. Earnings per share was 375.11.

Revenue	39.19B
Gross Profit	18.66B
Operating Income	3.99B
Pretax Income	4.65B
Net Income	3.65B
EBITDA	10.01B
EBIT	3.99B
Earnings Per Share (EPS)	375.11

Full Income Statement

Balance Sheet

The company has 18.14 billion in cash and 11.15 billion in debt, giving a net cash position of 6.99 billion or 731.28 per share.

Cash & Cash Equivalents	18.14B
Total Debt	11.15B
Net Cash	6.99B
Net Cash Per Share	731.28
Equity (Book Value)	96.09B
Book Value Per Share	9,948.04
Working Capital	28.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.41 billion and capital expenditures -5.02 billion, giving a free cash flow of 1.39 billion.

Operating Cash Flow	6.41B
Capital Expenditures	-5.02B
Free Cash Flow	1.39B
FCF Per Share	145.12

Full Cash Flow Statement

Margins

Gross margin is 47.62%, with operating and profit margins of 10.18% and 9.31%.

Gross Margin	47.62%
Operating Margin	10.18%
Pretax Margin	11.86%
Profit Margin	9.31%
EBITDA Margin	25.53%
EBIT Margin	10.18%
FCF Margin	3.54%

Dividends & Yields

This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 1.44%.

Dividend Per Share	150.00
Dividend Yield	1.44%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	1
Payout Ratio	26.75%
Buyback Yield	0.94%
Shareholder Yield	2.37%
Earnings Yield	3.50%
FCF Yield	1.36%

Dividend Details

Stock Splits

The last stock split was on July 18, 2018. It was a forward split with a ratio of 1.2.

Last Split Date	Jul 18, 2018
Split Type	Forward
Split Ratio	1.2

Scores

Choong Ang Vaccine Laboratory has an Altman Z-Score of 5.35.

Altman Z-Score	5.35
Piotroski F-Score	n/a